Dogwood Therapeutics revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, DWTX annual revenue was $0.0, with N/A growth year-over-year.
DWTX revenue history
Current Revenue
$0.0
Current Earnings
-$12.9M
Current Profit Margin
0%
Be the first to know when DWTX announces revenue.
DWTX Revenue History By Year
DWTX Yearly Revenue
DWTX Revenue
DWTX Change
DWTX Revenue Growth
2024-12-31
$0.00
N/A
N/A
2023-12-31
$0.00
N/A
N/A
2022-12-31
$0.00
N/A
N/A
2021-12-31
$0.00
N/A
N/A
2020-12-31
$0.00
N/A
N/A
2019-12-31
$0.00
N/A
N/A
2018-12-31
$0.00
N/A
N/A
1 of 1
Dogwood Therapeutics Revenue FAQ
What was DWTX's revenue last quarter?
Dogwood Therapeutics (NASDAQ: DWTX) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Dogwood Therapeutics's revenue was $0.00.
What was Dogwood Therapeutics's revenue in 2024?
Dogwood Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
How much does Dogwood Therapeutics make in a day?
Based on Dogwood Therapeutics annual revenue for the past five years, DWTX makes an average of $0.00 per day.
What was Dogwood Therapeutics's annual revenue growth in the past year?
As of Q2 2025, Dogwood Therapeutics's revenue has grown null year over year. Dogwood Therapeutics's revenue in the past year totaled $0.00.
How much does Dogwood Therapeutics make in a year?
Dogwood Therapeutics's revenue by year for the past five years is:
Dogwood Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
Dogwood Therapeutics's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
Dogwood Therapeutics's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
Dogwood Therapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
Dogwood Therapeutics's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.